Search clinical trials for: SARS CoV-2

Total 48420 results

University of Iowa
3M

Withdrawn

Povidone Iodine Nasal Application to Prevent Intraoperative Spread of SARS-CoV-2

SARS-CoV-2 Acute Respiratory Disease
Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older (VAT00008)

COVID-19

United States, Colombia, Ghana, Honduras, India, Japan, Kenya, Mexico, Nepal, Nigeria, Sri Lanka, Uganda, Ukraine
The Second Affiliated Hospital of Chongqing Medical...

Recruiting

Safety and Immune Response of COVID-19 Vaccination in Patients With Basic Disease (SIM-PBD)

Covid19 | Adverse Reaction to Vaccine | Diseases, Chronic

China
Osman ERGANIS, PhD, Prof
The Scientific and Technological Research Council of Turkey; MonitorCRO; VETAL...

Terminated

Study of a Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Adjuvanted Inactivated Vaccine in Healthy Adults (COVID-19)

Covid19

Turkey
Stanford University

Completed

Safety, Tolerability, and Pharmacokinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY) (COVID-19)

Covid19

Australia
Xijing Hospital

Completed

Epileptic Seizure in Epilepsy Patients After SARS-CoV-2 Vaccination

Vaccine Adverse Reaction | SARS-CoV-2 Acute Respiratory Disease | Epileptic Seizures Related to Drugs

China
Kingman Regional Medical Center

Completed

Prevalence of COVID-19 Antibodies Kingman AZ

Covid19

United States
Magdalena Salcedo

Unknown

Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocompetent Patients

Liver Transplant Infection | Covid19 | Mortality | Immune Response

Spain
Massachusetts General Hospital

Completed

In Utero Exposure to SARS-CoV-2 (COVID-19) and Cardiovascular and Metabolic Endpoints in Early Life (PROSPER)

In Utero SARS-CoV-2 Exposure

United States
Children's Hospital of Chongqing Medical University

Recruiting

Passive Transmission of COVID-19 Antibody From Mother to Infant

Passive Transmission of Maternal and Infant Antibodies

China
The Second Affiliated Hospital of Chongqing Medical...

Recruiting

Safety and Immune Response of COVID-19 Vaccination in Overweight People With Excessive BMI

Covid19 | Overweight

China
University of Wisconsin, Madison

Completed

Immunogenicity of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease

IBD | Covid19 Vaccine

United States
Hannover Medical School
Universitätsklinikum Hamburg-Eppendorf; German Center for Infection Research; IDT Biologika

Terminated

Safety, Reactogenicity and Immunogenicity of a Novel MVA-SARS-2-ST Vaccine Candidate

COVID-19 Vaccines

Germany
Kern Medical Center

Completed

Social Determinants of Health in Patients With Penetrating Trauma Injuries Before and During the COVID-19 Pandemic

COVID-19 | Social Determinants of Health | Penetrating Injury

United States
Karolinska University Hospital
Karolinska Institutet

Recruiting

A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study

Covid-19

Sweden
Asociacion para el Estudio de las Enfermedades...

Recruiting

Differences in Immune Response Among HIV-1-infected Individuals With Previous or Current COVID-19 (CoVIHDis). (CoVIHDis)

Covid19 | HIV-1-infection | Immune Suppression

Spain
MiNK Therapeutics

Completed

Evaluate the Safety of agenT-797 in Participants With Moderate to Severe Difficulty Breathing Secondary to SARS-CoV-2

Respiratory Distress Syndrome, Adult

United States
Centre Hospitalier Régional d'Orléans
Institut Pasteur

Completed

Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection (ABCOVID)

Covid19 | SARS-CoV-2

France
The Herb, Inc
ProRelix Services LLP

Completed

Study to Evaluate Efficacy and Safety of "VIRACIDE" IN THE MANAGEMENT OF CORONA VIRUS DISEASE 2019 (COVID-19)

Covid19

India
Corpometria Institute

Completed

EAT-DUTA AndroCoV Trial

Covid19

Brazil
GeoVax, Inc.
National Cancer Institute (NCI)

Recruiting

SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer

Lymphoma | Leukemia | Plasma Cell Myeloma | Hematopoietic and Lymphoid System Neoplasm | COVID-19 Infection

United States
Beijing Minhai Biotechnology Co., Ltd
Shenzhen Kangtai Biological Products Co., LTD; Jiangsu Province Centers for...

Unknown

A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)

COVID-19

China
Cocrystal Pharma, Inc.
Cocrystal Pharma Australia Pty Ltd.; Nucleus Network Pty Ltd.; Beyond Drug Development... and other collaborators

Recruiting

CDI-988 Safety Study in Healthy Participants

Healthy Volunteers

Australia
Israel Institute for Biological Research (IIBR)

Completed

Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine

Covid19

Israel
Suzhou Kintor Pharmaceutical Inc,

Terminated

A Study to Evaluate the Efficacy and Safety of Proxalutamide (GT0918) in Hospitalized COVID-19 Subjects

Covid19

United States, China, Philippines, South Africa, Ukraine
Becton, Dickinson and Company

Completed

BD Veritor™ At-Home and BD Veritor™ Professional

Upper Respiratory Infection

New Zealand, Australia, United States
Istituto Auxologico Italiano

Completed

Security Efficacy COVID-19 Vaccination (SECVAX)

SARS-CoV-2 Infection | Autoimmune State

Italy
Todos Medical, Ltd.

Completed

Effect of Daily Oral Administration of Food Supplement NLC-V in Patients Diagnosed With COVID-19

COVID-19

Israel
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo; Conselho Nacional de...

Active, not recruiting

CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms (CANDIDATE)

SARS-CoV2

Brazil
Pfizer

Recruiting

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

COVID-19

United States, United Kingdom, Mexico, South Africa, Japan, Bulgaria, Hungary, Puerto Rico
NYU Langone Health

Recruiting

Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 (PASC) Using TSPO Positron Emission Tomography (PET) and MRI

Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 Infection

United States
Imunon

Recruiting

Study to Evaluate the Safety & Immunogenicity of IMNN-101 Administered in Healthy Adults Previously Vaccinated Against SARS-CoV-2

SARS CoV 2 Infection

United States
Imperial College London

Withdrawn

Recovering From COVID-19 (OVER-COVID)

SARS CoV 2 Infection
Rutgers, The State University of New Jersey
National Institute of Dental and Craniofacial Research (NIDCR)

Completed

Rutgers Pilot for PREDICT- Patient POC Test

SARS CoV 2 Infection

United States
Alvea Holdings, LLC

Completed

Safety, Tolerability and Immunogenicity of Alveavax-v1.2, a BA.2/Omicron-optimized, DNA Vaccine for COVID-19 Prevention

Sars-CoV-2 Infection

South Africa
Murdoch Childrens Research Institute
Rhinomed Pty Ltd

Completed

Diagnosis of Respiratory Viruses in Children With Rhinoswab Junior

COVID-19 | SARS CoV 2 Infection

Australia
First Affiliated Hospital Xi'an Jiaotong University

Completed

Effectiveness of COVID-19 Vaccines Against the SARS-COV-2 Delta (B.1.617.2) (FASTER)

SARS CoV 2 Infection

China
Ospedale Generale Di Zona Moriggia-Pelascini

Completed

Cognitive, Emotional and Behavioural Impairments in Patients After Sars-Cov2 Infection

COVID-19 | Sars-CoV-2 Infection

Italy
Toscana Life Sciences Sviluppo s.r.l.
Cross Research S.A.

Completed

Study to Evaluate the Safety and Concentrations of Monoclonal Antibody Against Virus That Causes COVID-19 Disease. (MAD0004J08)

COVID-19 Virus Disease

Italy
The Second Affiliated Hospital of Chongqing Medical...

Recruiting

Safety and Immune Response of COVID-19 Vaccination in Patients With Chronic Liver Diseases (SIMPLE)

Liver Diseases | Covid19 | Adverse Reaction to Vaccine

China
Immuno Cure 3 Limited
The University of Hong Kong

Active, not recruiting

Immunogenicity and Safety Study of SARS-CoV-2 DNA Vaccine (ICCOV)

COVID-19

Hong Kong
Grand Hôpital de Charleroi

Completed

COVID-19 Seroconversion Study Among GHdC Staff Members - Summer 2020

Covid19

Belgium
Dr. Francisco Ciruela Alférez
Hospital Universitario de Bellvitge; Gerencia Territorial del Área Metropolitana... and other collaborators

Completed

SCREENING AND SEROEPIDEMIOLOGY OF SARS-CoV-2 INFECTION AT THE UNIVERSITY OF BARCELONA: A CROSS-SECTIONAL STUDY (UB-GTMS-COVID)

SARS-CoV-2 Infection

Spain
Hospital Italiano de Buenos Aires
Roche Pharma AG

Unknown

Serologic Surveillance for SARS-CoV-2 (COVID-19) in a Prospective Cohort of Health Care Workers

COVID-19 | SARS-CoV 2 | Health Personnel
Certara
Bill and Melinda Gates Foundation; Parexel

Completed

International Registry of Healthcare Workers Exposed to COVID-19 Patients (UNITY Global) (UNITY Global)

Covid19 | SARS-CoV Infection

Pakistan
ModernaTX, Inc.

Recruiting

Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273.214 SARS-CoV-2 (COVID-19) Vaccine in Infants (BabyCOVE)

SARS-CoV-2

United States
University of Erlangen-Nürnberg Medical School

Recruiting

SARS-CoV2 Antibodies in Pediatric Patients (COVID-19) (SARS-CoV2_KIDS)

SARS-Cov2

Germany
Universitair Ziekenhuis Brussel

Recruiting

SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel During the 2020 COVID-19 Outbreak (COVEMUZ)

Sars-CoV2

Belgium
ModernaTX, Inc.

Completed

A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age

SARS-CoV-2

United States, Canada
Glycovax Pharma Inc.
Government of Canada; JSS Medical Research Inc.; Seppic; Avance Clinical Pty Ltd.

Active, not recruiting

Safety and Immunogenicity of Glycovax-002 Vaccine in Healthy Adults

SARS-CoV-2

Australia

Search clinical trials for: SARS CoV-2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations